Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT

Rainer Storb, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, elaborates on the most suitable method of myeloablative conditioning prior to allogeneic hematopoietic cell transplant (ASCT) for patients with myeloid malignancies. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.